The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial
European and Developing Countries Clinical Trials Partnership
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial
Pontiano Kaleebu, Moses Sewankambo, Alex Mutebe, Paul L. A. M. Corstjens et al.
Citations
10 citations
Journal
The Lancet Global Health
Topics
Parasites and Host Interactions
Field-Weighted Citation Impact (FWCI)
5.16
article
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial
Pontiano Kaleebu, Moses Sewankambo, Alex Mutebe, Paul L. A. M. Corstjens, Emily L. Webb, Gyaviira Nkurunungi, John Kayiwa, Christopher Zziwa, Govert J. van Dam, Bridgious Walusimbi, Prossy Kabuubi, Samuel Kiwanuka, Agnes Natukunda, Alison M. Elliott, Caroline Ninsiima, Stephen Cose, Anne Wajja, Florence Akello, Ludoviko Zirimenya, Jacent Nassuuna, Esther Nakazibwe, Moses Kizza, Joyce Kabagenyi
article en
10 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Global HealthVol. 12(11)
Institutions
Leiden University Medical Center (NL), London School of Hygiene & Tropical Medicine (GB), Uganda Virus Research Institute (UG)
Funders
Wellcome Trust, National Institute for Health and Care Research, Medical Research Council, European and Developing Countries Clinical Trials Partnership